Auto-Adjustable MOBIDERm Autofit Armsleeve in the Management of Upper Limb Lymphedema.
This study aims to assess Auto-Adjustable MOBIDERM® Autofit Armsleeve effect on upper limb volume excess compared to the compression bandages to manage the volume of upper limb lymphedema in patients with breast cancer related lymphedema
- EligibilityCriteria: Inclusion Criteria:  Unilateral secondary upper limb lymphedema of stage II or III according to the criteria defined by the International Society of Lymphology, following breast cancer Volume difference between affected and healthy arm ≥ 10% Affected arm that fits with one of the 6 standard sizes of the Auto- Adjustable MOBIDERM Autofit armsleeve provided. Signed informed consent prior to any study-mandated procedure.  Exclusion Criteria:  Stage I lymphedema or located in several places. Patients for whom compression is contraindicated. Lymphedema associated with active cancer needing acute chemotherapy or having recurrence or metastasis. Motor and sensitive neurological deficiency / psychiatric or addictive disorders Pregnant or breastfeeding patient Patient intolerant to MOBIDERM Autofit or known allergies to the components used. Participation to any other clinical study which has an impact on the different endpoints Vulnerable patient, adults being the object of a legal protective measure or enable to express their consent. - HealthyVolunteers: No - Gender: Female - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult